Multiple Assemblies exist for SMTL entry 6ega
IRAK4 in complex with a type II inhibitor; X-RAY DIFFRACTION 2.51 Å

	SMTL ID 6ega.1 Ligands 3-{2-[(cyclopropanecarbonyl)amino][1,3]thiazolo[5,4-b]pyridin-5-yl}-N-{4-[(piperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide; SULFATE ION; COBALT (II) ION Polypeptides Interleukin-1 receptor-associated kinase 4 Oligo-state homo-dimer
	SMTL ID 6ega.2 Ligands 3-{2-[(cyclopropanecarbonyl)amino][1,3]thiazolo[5,4-b]pyridin-5-yl}-N-{4-[(piperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide; SULFATE ION; COBALT (II) ION Polypeptides Interleukin-1 receptor-associated kinase 4 Oligo-state homo-tetramer